High Total Antioxidant Capacity Products Added to Diet

High Total Antioxidant Capacity (TAC) Products Added to Diet: Clinical and Instrumental Evaluation of Their Effect on Skin Surface Parameters and on Photo-induced Acute Damage of the Skin (Double Blind Clinical Study vs Placebo)

The purpose of this study is to evaluate the antioxidant activity on skin photo induced damage of a food supplement and its anti-age properties.

Study Overview

• Status: Completed
• Conditions: Healthy
• Intervention / Treatment: Dietary supplement: Alixir - Pomegranate, apple and Açai drink / Placebo

Detailed Description

To determine the antioxidant activity of the tested product the following clinical and instrumental evaluations will be performed:

1. Evaluation of experimentally induced erythema inhibition: in basal conditions, before starting the assumption of the test product/placebo, and at T4, T8, T12, T16 weeks, each volunteer wll be exposed at the level of dorsal skin to six incremental doses of UVR (ultraviolet radiations mJ/cm2 ) in order to determine the MED (minimal erythema dose of unprotected skin). 20+/-4 hours after the UV exposure clinical and instrumental (optical densitometry) evaluations of skin erythema and photographic documentation (only on 16 preselected cases) will be performed.
2. Blood samples collection for the determination of the principal antioxidants concentration (for example: lutein, carotene, lycopene and E vitamin): at T0, T4, T8 and T12 blood samples (5 ml of venous blood) will be collected on each volunteer by the Medical Staff. The samples will be sent to an external laboratory for haematologic control task.

To determine the anti-age properties of the tested product the following clinical and instrumental evaluations will be performed:

1. Non Invasive, instrumental evaluation of principal skin parameters: epicutaneous pH, skin hydration (skin electrical capacitance), skin firmness (plastoelasticity), skin texture (skin surface irregularity index - FFT on skin replicas) measurements will be performed at T0 and T8 mono-laterally at level of volar forearm medium third, left or right side according to a previously defined randomization list.
2. Clinical pictures with UV flash (Wood's light): at T0 and T8, 20 preselected cases of fairy skinned volunteers (selected on the basis of clinical ananmnesis regarding photosensitivity) will be submitted to the realization of clinical pictures at the level of the face using a special UV flash, able to highlight melanin spots, even if not yet visible at the naked eye.

Moreover aim of the study is also to evaluate the best dosage of the beverage (1 or 2 servings of 250 ml/a day).

• Study Type: Interventional
• Enrollment (Actual): 120
• Phase: Phase 3

Contacts and Locations

Study Locations

• Italy
  • MB
    • Monza, MB, Italy, 20052
      • DermIng S.r.l

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 30 years to 60 years (ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Adult volunteers of both sexes, between 30 and 60 years of age
• Phototype II or III ( Fitzpatrick's classification)
• Volunteers in a good general state of health in the Investigator opinion
• Volunteers not taking drugs or undergoing surgical procedure
• Volunteers who are giving a written informed consent

Exclusion Criteria:

• pregnancy
• lactation
• smoking >10 cigarettes per day
• drinking more then one glass of wine per day
• drinking super-alcoholics
• assumption of food supplement
• change in the normal habits in the last month
• participation in a similar study during the previous 3 months
• insufficient adhesion to the study protocol
• dermatological disease
• clinical and significant skin condition on the test area (e.g. lesions, scars,malformations)
• diabetes
• endocrine disease
• hepatic, renal or cardiac disorder
• cancer
• topical drugs or surgical procedure on the test areas during the previous 3 months
• systemic corticosteroids
• aspirin or non-steroid anti-inflammatory drugs (FANS)
• diuretic drugs
• antibiotics and chemotherapics
• psychotropic drugs
• retinoids
• psoralens
• cardiologic and vascular drugs

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: FACTORIAL
• Masking: DOUBLE

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Group 1 Product 825 (2-servings day); 30 subjects drinking 2 servings day of Product 825 for 8 weeks	Dietary supplement: Alixir - Pomegranate, apple and Açai drink / Placebo; 250 ml/day Alixir/Placebo for Group 2 for 8 weeks 500 ml/day Alixir/Placebo for Group 1 for 8 weeks; Other Names: Barilla Alixir (code 824/825); Anti-oxidant drink; Açai drink
EXPERIMENTAL: Group 1 Product 824 (2 servings-day); 30 subjects drinking 2 servings-day of Product 824 for 8 weeks	Dietary supplement: Alixir - Pomegranate, apple and Açai drink / Placebo; 250 ml/day Alixir/Placebo for Group 2 for 8 weeks 500 ml/day Alixir/Placebo for Group 1 for 8 weeks; Other Names: Barilla Alixir (code 824/825); Anti-oxidant drink; Açai drink
EXPERIMENTAL: Group 2 Product 825 (1 serving-day); 30 subjects drinking 1 serving-day of Product 825 for 8 weeks	Dietary supplement: Alixir - Pomegranate, apple and Açai drink / Placebo; 250 ml/day Alixir/Placebo for Group 2 for 8 weeks 500 ml/day Alixir/Placebo for Group 1 for 8 weeks; Other Names: Barilla Alixir (code 824/825); Anti-oxidant drink; Açai drink
EXPERIMENTAL: Gruop 2 Product 824 (1 serving-day); 30 subjects drinking 1 serving-day of Product 824 for 8 weeks	Dietary supplement: Alixir - Pomegranate, apple and Açai drink / Placebo; 250 ml/day Alixir/Placebo for Group 2 for 8 weeks 500 ml/day Alixir/Placebo for Group 1 for 8 weeks; Other Names: Barilla Alixir (code 824/825); Anti-oxidant drink; Açai drink

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Erythema evaluation (MED-optical densitometry)	T0 (basal conditions), T4 and T8 (after 4 and 8 week-treatment), T12 and T16 (follow-up visits - 12 and 16 weeks after T0)

Secondary Outcome Measures

Outcome Measure	Time Frame
Skin evaluations (Skin texture - Hydration - Plastoelasticity - Epicutaneous pH)	T0 and T8 for skin evaluations - T0, T4, T8 and T12 for blood analysis
Determination on blood samples of antioxidants diet components	T0 and T8 for skin evaluations - T0, T4, T8 and T12 for blood analysis

Collaborators and Investigators

• Sponsor: Derming SRL
• Collaborators: University of Bologna

Publications and helpful links

General Publications

• Elsner P., Berardesca E., Maibach H. Bioengineering of the skin: Water and the stratum corneum CRC Press, Boca Raton, 1994; Fuga GC, Spina C, Cavallotti C, Di Palma A, Lombardi G, Marmo W Computerized reflected optical densitometry. A research on the colour of the skin - Journal of Applied Cosmetology, 8:91-110,1990; Cosmetic, Toiletry and Fragrance Association of South Africa (CFTA), The European Cosmetic Toiletry and Perfumery Association (COLIPA), Japan Cosmetic Industry Association (JCIA) International sun protection factor (SPF) test method; October 2002; ICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: May 1996; Setaro M., Sparavigna A. Morphological Evaluation of Skin Surface by Fourier's Transform: A Study on the Phase and the Modulus

Helpful Links

• Investigator center
• Sponsor
• Haematological laboratory center

Study record dates

Study Major Dates

• Study Start: February 1, 2010
• Primary Completion (ACTUAL): July 1, 2010
• Study Completion (ACTUAL): October 1, 2010

Study Registration Dates

• First Submitted: September 10, 2009
• First Submitted That Met QC Criteria: September 10, 2009
• First Posted (ESTIMATE): September 11, 2009

Study Record Updates

• Last Update Posted (ESTIMATE): June 23, 2011
• Last Update Submitted That Met QC Criteria: June 22, 2011
• Last Verified: June 1, 2011

More Information

Terms related to this study

• Keywords: Food supplement; Anti-oxidant; Sun protection; Açai; Skin erythema prevention; Anti-oxidant efficacy; Anti-age efficacy; Skin photo-induced damage protection
• Additional Relevant MeSH Terms: Physiological Effects of Drugs; Molecular Mechanisms of Pharmacological Action; Protective Agents; Antioxidants
• Other Study ID Numbers: DermIng E0709